The company trades aluminum products such as coils, foils, sheets, and strips, primarily serving industrial customers in India.
The company operates as a pure commodity trader with no proprietary technology or cost advantages, evidenced by negative average ROCE and razor-thin net margins. The lack of pricing power is confirmed by the fact that despite a massive revenue surge, the business barely generates any absolute profit.
Management has failed to generate positive returns on capital over the cycle, with average ROCE at -1.0%. Capital is primarily tied up in working capital (receivables) rather than productive assets, and no dividends are paid due to lack of meaningful earnings.
The massive revenue growth proved to be a mirage of circular trading with related parties, serving no purpose other than to inflate the top line while the business bled cash. As receivables from these insiders aged and eventually became uncollectible, the lack of real-world cash flow forced a liquidity crisis. The market finally realized that a commodity trader with negative returns on capital and no proprietary advantage is not a business, but a shell for moving money, leading to a total collapse in the share price as the auditor's 'pre-occupation' was revealed to be a flight from systemic accounting irregularities.
RichFakir rates Worldwide Aluminium Ltd's business quality as poor — 20/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Worldwide Aluminium Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Worldwide Aluminium Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Worldwide Aluminium Ltd's fair value is about ₹2 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →